CHD1Li 6.11

• Description:

  CHD1Li 6.11 is a potent inhibitor of oncogenic CHD1L, acting on the cat-CHD1L recombinant protein (IC50: 3.3 μM) . CHD1Li 6.11 is an orally active antitumour agent that significantly reduces the tumour volume of CRC xenografts generated from isolated quasi-mesenchymal cells (M phenotype) with enhanced tumourigenic properties. These cells have enhanced tumourigenic properties.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  472.4

• Molecular Formula:

  C21H22BrN5OS

• Notes:

  Research use only, not for human use.

• Receptor:

  Others

• CAS Number:

  2716890-91-2